Phase 3 Focal Seizure Clinical Trials

3 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–3 of 3 trials

Recruiting

Phase 3

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

EpilepsyFocal EpilepsyFocal Seizure

Rapport Therapeutics Inc.333 enrolled4 locationsNCT07563881

Recruiting

Phase 3

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

EpilepsyFocal EpilepsyFocal Seizure

Rapport Therapeutics Inc.312 enrolled5 locationsNCT07594119

Recruiting

Phase 2Phase 3

Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)

Focal Seizure

Praxis Precision Medicines230 enrolled26 locationsNCT06999902